Profusa Inc (PFSA) — Institutional Holders Breakdown (Q2 2026)

AI summary pending

No AI summary for this filing type

On August 12, 2026, Profusa, Inc. (ticker: PFSA) signed the fifth amendment to its securities purchase agreement with investor Ascent Partners Fund LLC and completed an additional closing under it, issuing Ascent a senior secured convertible note with a face value of about $714,286 in exchange for $650,000 in cash. The note pays 7% annual interest, matures on August 12, 2027, converts into common stock at $1.07 per share, and is backed by substantially all of the company's assets. The same amendment also reset the exercise price of a warrant previously issued to Ascent to $1.07 per share. On top of that, on August 19, 2026, Profusa agreed to swap some of its existing notes with Ascent for newly created non-voting convertible preferred stock — though the filing excerpt cuts off before spelling out all the exchange terms.

AI summary pending

AI summary pending

Profusa signed an option agreement on July 31, 2026 giving it the right — but not the obligation — to buy all of G3 Vision Labs' equity, which would also bring Med Screen, Dominion and Acutis under its umbrella. As upfront consideration, Profusa issued the sellers roughly 201,120 common shares and 52,903.566 shares of a new Series A convertible preferred stock; if it exercises the option, it will issue another 53,918.113 preferred shares. The deal only closes if a long list of conditions is met, including at least $30 million in new financing, refinancing G3's debt, stockholder approval of the preferred conversion and the Nasdaq-related proposals, and continued Nasdaq listing. The call option expires 90 days after the target companies deliver certain audited or reviewed financials.

Profusa (ticker PFSA) announced several leadership changes on July 20: director Jack Stover was appointed Executive Chairman and CEO, tasked with closing an upcoming transaction (referenced in Item 8.01) and leading the combined diagnostics platform. Former CEO and Chairman Ben Hwang became President but resigned from the board on July 26, keeping his President role. The same day, the board elected Liviu Goldenberg as an independent director to fill the vacancy. Goldenberg brings over 30 years of experience in tech, manufacturing, and ESG.

Profusa, Inc. filed an 8-K on July 2, 2026, disclosing amendments to its certificate of incorporation or bylaws that affect shareholder rights. The filing also references other events and related financial exhibits, with the specifics covered in Item 5.03.